Gary L. Davis

Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

Gary L. Davis, Luis A. Balart, Eugene R. Schiff et al. · New England Journal of Medicine · 1989 · 1.7K citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

Gary L. Davis, Rafael Esteban, Vinod K. Rustgi et al. · New England Journal of Medicine · 1998 · 1.3K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +9

The major human rhinovirus receptor is ICAM-1

Jeffrey M. Greve, Gary L. Davis, Ann Meyer et al. · Cell · 1989 · 1.1K citations

Life Sciences, Immunology, Molecular Biology +12

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

Gary L. Davis, Miriam J. Alter, Hashem B. El‐Serag et al. · Gastroenterology · 2009 · 882 citations · Full text

Education, Geriatric Medicine, Infectious Diseases +10

Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis C

Gary L. Davis, John B. Wong, John G. McHutchison et al. · Hepatology · 2003 · 820 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17